Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2021-2028

GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2021-2028

The global multiplex assay market is estimated to register a CAGR of 8.74% over the forecast period and is expected to generate revenue of $7922.13 million by 2028.  While the base year considered for the market study is 2020, the forecasting years are from 2021 to 2028.

GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2021-2028

 

Global Multiplex Assay Market by Type ( Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Multiplex Assays ) Market by Product ( Reagents and Consumables, Instruments and Accessories, Software and Services ) Market by Technology ( Multiplex Protein Microarray, Multiplex Pcr, Other Technologies ) Market by Application ( Clinical Diagnostics, Research and Development, Companion Diagnostics ) Market by End-user ( Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies ) by Geography.

Request free sample

Report Summary

The global multiplex assay market is estimated to register a CAGR of 8.74% over the forecast period and is expected to generate revenue of $7922.13 million by 2028.  While the base year considered for the market study is 2020, the forecasting years are from 2021 to 2028.

Multiplex assay is a process in which various analytes such as biomolecules, cytokines, proteins, chemokines, and others are profiled by quantifying and detecting them simultaneously.multiplex-assay-market

To know more about this report, request a free sample copy.

Key factors propelling the global multiplex assay market growth:

  • Governmental funding and R&D activities
  • Preference of multiplex assays over conventional assays
  • Adoption of personalized medicines
    • Multiplex assays are used for panel-based tests, expected to detect variations in genes in one assay cycle.
    • The adoption of personalized medicines is anticipated to continue increasing during the analysis period.

Major growth restraining factors:

  • Unavailability of skilled lab technicians
    • The dearth of skilled technologists and lab technicians possessing advanced laboratory expertise, experience, and knowledge, is particularly witnessed in remote healthcare organizations. This factor restrains the market growth.
  • Compliance with strict environmental regulation

The report scope of the global multiplex assay market includes segmentation analysis based on product, type, technology, application, and end-user. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Technology:

  • Multiplex Protein Microarray
    • The multiplex protein microarray segment dominated the technology category in 2020.
    • Multiplex protein microarray is a technique used for analyzing protein interactions to understand the functionality of proteins.
  • Multiplex PCR
    • Multiplex PCR is the fastest-growing technology.
    • It is a molecular technique used for the multiplication of multiple targets in a single PCR reaction.
    • Multiple primers are used in multiplex PCR for amplifying more than one target sequence.
  • Other Technologies

Geographically, the global multiplex assay market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is set to hold the highest market share by 2028.
    • Multiplex PCR observes extensive usage in the United States due to its growing application in the molecular detection of various cancers and infectious diseases.
    • Moreover, the United States spends significantly higher on healthcare than any other country in the world, thereby boosting the North America market.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
    • The Asia-Pacific is the fastest-growing region across the global market.
    • As the geriatric population rapidly increases in many Asia-Pacific countries, the burden of infectious diseases is also expected to rise.
    • This factor is anticipated to increase the demand for technologies, primarily for diagnosis and research.
  • Rest of World: Latin America, the Middle East & Africa

Major players in the global multiplex assay market:

  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • Hoffmann-la Roche
  • Qiagen NV
  • Thermo fisher scientific Inc

Key strategies adopted by some of these companies:

In April 2021, Bio-Techne launched Professional Assay Services, a dedicated basis for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis.

Key findings of the global multiplex assay market:

  • Surging in-vitro diagnostics technologies play a vital role in fueling the global multiplex assay market growth.
  • The identification of novel biomarkers provides the global market with immense growth prospects.
  • Emerging economies of the LAMEA and Asia-Pacific regions offer lucrative opportunities for the global market’s expansion.

 

Frequently Asked Questions (FAQs):

  • Why is the demand for multiplex assay anticipated to surge in developing economies?

A: The rising incidence of various chronic and infectious diseases across developing countries, as well as an increase in the research required for the development of drugs to cure diseases, have boosted the demand for multiplex assays.

  • What is the impact of the COVID-19 on the global multiplex assay market?

A: Due to the COVID-19 outbreak in 2020, several research institutes indulged in finding the systematic cure for the deadly coronavirus infection, requiring extensive use of multiplex assay products. For instance, ThermoFisher developed the Applied Biosystems TaqPath COVID-19 kit. It is a highly sensitive and fast multiplex diagnostic solution containing both the controls and assays needed for the real-time PCR detection of RNA from the novel coronavirus.

Table of Contents

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • GOVERNMENTAL FUNDING AND R&D ACTIVITIES
      • PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
      • ADOPTION OF PERSONALIZED MEDICINES
    • KEY RESTRAINTS
      • UNAVAILABILITY OF SKILLED LAB TECHNICIANS
      • COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATIONS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRY
      • INDUSTRY RIVALRY
    • KEY BUYING CRITERIA
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY TYPE
    • PROTEIN-BASED MULTIPLEX ASSAY
    • NUCLEIC ACID-BASED MULTIPLEX ASSAY
    • OTHER MULTIPLEX ASSAYS
  3. MARKET BY PRODUCT
    • REAGENTS AND CONSUMABLES
    • INSTRUMENTS AND ACCESSORIES
    • SOFTWARE AND SERVICES
  4. MARKET BY TECHNOLOGY
    • MULTIPLEX PROTEIN MICROARRAY
    • MULTIPLEX PCR
    • OTHER TECHNOLOGIES
  5. MARKET BY APPLICATION
    • CLINICAL DIAGNOSTICS
    • RESEARCH AND DEVELOPMENT
    • COMPANION DIAGNOSTICS
  6. MARKET BY END-USER
    • HOSPITALS
    • CLINICAL LABORATORIES
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  7. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • COMPANY PROFILES
      • ABCAM
      • AGILENT TECHNOLOGIES INC
      • BECTON, DICKINSON AND COMPANY (BD)
      • BIO-RAD LABORATORIES INC
      • BIO-TECHNE CORPORATION
      • HOFFMANN-LA ROCHE
      • ILLUMINA INC
      • LUMINEX CORPORATION
      • MERCK MILLIPORE
      • OLINK PROTEOMICS AB
      • QIAGEN NV
      • RANDOX LABORATORIES LTD
      • SEEGENE INC
      • SIEMENS HEALTHINEERS AG
      • THERMO FISHER SCIENTIFIC INC
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ABCAM PLC.
      • AGILENT TECHNOLOGIES, INC.
      • BECTON DICKINSON AND COMPANY
      • BIO-RAD LABORATORIES, INC.
      • BIO-TECHNE CORPORATION
      • ILLUMINA, INC
      • LUMINEX CORPORATION
      • MERCK MILIPORE
      • MESO SCALE DIAGNOSTICS, LLC
      • OLINK PROTEOMICS AB
      • QIAGEN N.V.
      • RANDOX LABORATORIES LTD.
      • SEEGENE INC.
      • SIEMENS HEALTHINEERS
      • THERMO FISHER SCIENTIFIC INC.

TABLE LIST

TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY

TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL PROTEIN-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL MULTIPLEX PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL MULTIPLEX PCR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL OTHER TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 43: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: LEADING PLAYERS OPERATING IN THE NORTH AMERICA MULTIPLEX ASSAY MARKET

TABLE 49: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 50: EUROPE MULTIPLEX ASSAY, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 51: LEADING PLAYERS OPERATING IN EUROPE MULTIPLEX ASSAY MARKET

TABLE 52: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 53: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 54: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MULTIPLEX ASSAY MARKET

TABLE 55: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 56: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 57: LEADING PLAYERS OPERATING IN REST OF WORLD MULTIPLEX ASSAY MARKET

TABLE 58: LIST OF MERGERS & ACQUISITIONS

TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 61: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

FIGURE LIST          

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020

FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020

FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020

FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)

FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)

FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020

FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020

FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 28: UNITED STATES MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: CANADA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 31: GERMANY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: FRANCE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: ITALY MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: RUSSIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: BELGIUM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: POLAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 40: CHINA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: JAPAN MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: INDIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: THAILAND MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: INDONESIA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: VIETNAM MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: REST OF WORLD MULTIPLEX ASSAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 50: LATIN AMERICA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: MIDDLE EAST & AFRICA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)

Segmentation

  1. MARKET BY TYPE
    • PROTEIN-BASED MULTIPLEX ASSAY
    • NUCLEIC ACID-BASED MULTIPLEX ASSAY
    • OTHER MULTIPLEX ASSAYS
  2. MARKET BY PRODUCT
    • REAGENTS AND CONSUMABLES
    • INSTRUMENTS AND ACCESSORIES
    • SOFTWARE AND SERVICES
  3. MARKET BY TECHNOLOGY
    • MULTIPLEX PROTEIN MICROARRAY
    • MULTIPLEX PCR
    • OTHER TECHNOLOGIES
  4. MARKET BY APPLICATION
    • CLINICAL DIAGNOSTICS
    • RESEARCH AND DEVELOPMENT
    • COMPANION DIAGNOSTICS
  5. MARKET BY END-USER
    • HOSPITALS
    • CLINICAL LABORATORIES
    • RESEARCH INSTITUTES
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

Request Free Sample

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    RELATED REPORTS

    Author: shalini amarnani